ST
Sutro Biopharma, Inc.
STRO · NASDAQ
$19.10 -0.57% (-$0.11)
1M -25.19%
Market Cap $184.8M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$23.02
20.5% upside
Trenutna cena
$19.1
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica STRO trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
45 /100
Fair P/S 4.04x
P/E N/A
P/FFO N/A
Growth
87 /100
Growing Rev. growth 14.78%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 97.20%
FCF margin 318.63%
Net margin 395.25%
Quality
4 /100
Poor ROIC 95.49%
Asset turnover 0.24x
ROA 92.89%
Debt
43 /100
Moderate Current ratio 3.32x
Int. coverage -3.51x
Debt/Equity N/A
Stability
20 /100
Unstable Beta 1.49x
Profitable years 0
Rev. volatility 95.01%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o STRO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jane Chung
Employees
128
Headquarters
South San Francisco
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report